Articles: trauma.
-
Transplantation Case Report PosterSESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Neosartorya pseudofisheri is widely found in the soil and acquired by aeroinhalation. It is a distinct species, but morphologically similar to Aspergillus fumigatus. Although an uncommon human pathogen, it is primarily encountered in immunocompromised hosts. ⋯ The following authors have nothing to disclose: Diana Kelm, Mark Wylam, Steve Peters, Mark Wilhelm, John Scott, Cassie KennedyNo Product/Research Disclosure Information.
-
Cancer Case Report Posters IISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Bone is the third most common site for metastatic disease. However, the patella, for its poor vascular supply, is a rare place for metastasis, with only a few reports in the literature, mainly from breast and lung tumors. ⋯ Despite of being rare, distant neoplasms should be in the differential diagnosis of a common orthopedic symptom, as anterior knee pain.Reference #1: Wu B, Xiu Y, Jiang L, Shi H.; SPECT/CT imaging of patella metastasis from a squamous carcinoma of the lung; Clin Nucl Med. 2013 Feb; 38(2):125-7DISCLOSURE: The following authors have nothing to disclose: Marta Sousa, Vitor Melo, Eloisa Silva, Jorge Vale, João Silva, Bárbara Rodrigues, António TorresNo Product/Research Disclosure Information.
-
Surgery Case Report Posters ISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Chronic expanding thoracic hematoma (CETH) is a rare clinical entity mimicking invasive soft-tissue neoplasms in the thorax. It is reported to occur in patients with a history of trauma or surgery or tuberculosis. It is considered a form of chronic empyema and has also been designated as chronic hemorrhagic empyema. We present a case of a CETH, treated successfully with surgical resection. ⋯ The following authors have nothing to disclose: Danae Delivanis, Vanessa Yap, Daniel Fusco, Debapriya DattaNo Product/Research Disclosure Information.
-
Critical Care CasesSESSION TYPE: Case ReportsPRESENTED ON: Saturday, March 22, 2014 at 04:15 PM - 05:15 PMINTRODUCTION: The use of recombinant activated Factor VIIa(rFVIIa) was first approved in the United States in 1999 for treating bleeding episodes in patients with congenital and acquired Hemophilia A and B, hemophilia with inhibitors to factor VIII and IX, and surgical prophylaxis. The indications have been limited due to its risk of thrombosis. We are reporting a case of rFVIIa use for life threatening diffuse alveolar hemorrhage. ⋯ The following authors have nothing to disclose: Felix Hernandez, Michael Alvarez, Jose Ramirez, Gustavo FerrerNo Product/Research Disclosure Information.
-
Cardiovascular Case Report Posters IISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Some important indications for use of hyperbaric oxygen therapy include treatment of diabetic ulcers, air embolism, carbon monoxide poisoning, and gas gangrene. It is usually well tolerated with very few side effects. We describe a case of acute pulmonary edema precipitated by hyperbaric oxygen treatment. ⋯ The following authors have nothing to disclose: Manveen Dassan, Vishesh Paul, Sameer Chadha, Nidhi Aggarwal, Yizhak Kupfer, Sidney TesslerNo Product/Research Disclosure Information.